In drug screening assay, Imamura et al. (2017) used CRISPR/Cas9 mediated SOD1 corrected iPSCs lines generated from one ALS patient carrying the L144FVX mutation in the SOD1 gene and homologous arms corrected mutation as a control. Here, SOD1 is linked to amyotrophic lateral sclerosis.